Showing results (301-310 of 6,708) with videos related to
Sort By:
Pageof 671
Oncotargets and Therapy|May 17, 2021
IFNγ/PD-L1 Signaling Improves the Responsiveness of Anti-PD-1 Therapy in Colorectal Cancer: An in vitro StudyWenli Yuan, Deyao Deng, Hanyu Li, et al.Oncotargets and Therapy|May 17, 2021
Significant Benefits of Afatinib and Apatinib in a Refractory Advanced NSCLC Patient Resistant to Osimertinib: A Case ReportYuanyang Zhao, Yuxing Chen, Huaying Huang, et al.Oncotargets and Therapy|June 5, 2020
Optimal Management of First-Line Advanced Renal Cell Carcinoma: Focus on PembrolizumabAbhay Singh, Inderpreet Singh, Namrata Singh, et al.Oncotargets and Therapy|June 5, 2020
Elevated Levels of circRUNX1 in Colorectal Cancer Promote Cell Growth and Metastasis via miR-145-5p/IGF1 SignallingZhi-Lei Chen, Xiang-Nan Li, Chun-Xiang Ye, et al.Oncotargets and Therapy|June 5, 2020
Current Molecular Targeted Agents for Advanced Gastric CancerShanshan Nie, Guoping Yang, Hongwei LuOncotargets and Therapy|June 5, 2020
MiR-153-5p Enhances the Sensitivity of Triple-Negative Breast Cancer Cells to Paclitaxel by Inducing G2M Phase ArrestYang Wang, Nan Wu, Jun Zhang, et al.Oncotargets and Therapy|June 5, 2020
Rab18 Regulates Proliferation, Invasion and Cisplatin Sensitivity Through STAT3 Signaling in Head and Neck Squamous Cell CarcinomaXu Ji, Xing Guo, Yan Wang, et al.Oncotargets and Therapy|August 9, 2021
Glypican-1 Overexpression in Different Types of Breast CancersFatemah O F O Alshammari, Yousef M Al-Saraireh, Ahmed M M Youssef, et al.Oncotargets and Therapy|August 11, 2021
Acquired ALK Resistance Mutations Identified from Liquid Biopsy in an ALK-Rearranged Squamous Cell Lung Cancer Patient Treated with Sequential ALK TKI Therapy: A Case ReportBin Yao, Xue Han, Linrong Pang, et al.Oncotargets and Therapy|August 11, 2021
miR-765 Acts as a Tumor Promoter and Indicates Poor Prognosis in Non-Small Cell Lung CancerJiying Wang, Li Wang, Congjun ZhangPageof 671